Wuhan Puai Hospital
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
33%
2 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps
Role: collaborator
Improved Bowel Preparation Method for Colonoscopy Based on Different Risk Stratification
Role: collaborator
Multi-center Validation of a Deep Learning Based Bowel Preparation Evaluation System
Role: collaborator
Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy
Role: collaborator
Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients
Role: collaborator
Epidemiological Study of Colorectal Cancer in WuHan
Role: lead
All 6 trials loaded